Researchers surveyed 16- to 18-year-old undergraduates about their plans to become parents in England.
Eloxx moves ahead with plans with gene therapy for rare kidney disorder – Pharmaceutical Technology
Eloxx Pharmaceuticals is developing a therapy for the rare kidney disorder Alport syndrome. Credit: Ivan-balvan via Getty Images. US-based biotech Eloxx Pharmaceuticals announced the submission